Global Anti-Venom Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings.

Anti-Venom report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-Venom market is projected to reach US$ 1283.7 million in 2029, increasing from US$ 959.2 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029. Demand from Non-profit Institutions and Hospitals and Clinic are the major drivers for the industry.

CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Anti-Venom market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
    CSL
    Merck
    BTG
    Pfizer
    Haffkine Bio-Pharmaceutical
    Rare Disease Therapeutics
    Flynn Pharma
    Vins Bioproducts
    Bharat Serums and Vaccines
    Serum Biotech
    MicroPharm

Segment by Type
    Polyvalent Anti-Venom
    Monovalent Anti-Venom

Segment by Application
    Non-profit Institutions
    Hospitals and Clinic

Segment by Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Anti-Venom market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anti-Venom, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anti-Venom industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Anti-Venom in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anti-Venom introduction, etc. Anti-Venom Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Anti-Venom market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.

 1 Anti-Venom Market Overview
    1.1 Anti-Venom Product Overview
    1.2 Anti-Venom Market Segment by Type
        1.2.1 Polyvalent Anti-Venom
        1.2.2 Monovalent Anti-Venom
    1.3 Global Anti-Venom Market Size by Type
        1.3.1 Global Anti-Venom Market Size Overview by Type (2018-2029)
        1.3.2 Global Anti-Venom Historic Market Size Review by Type (2018-2023)
        1.3.3 Global Anti-Venom Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America Anti-Venom Sales Breakdown by Type (2018-2023)
        1.4.2 Europe Anti-Venom Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific Anti-Venom Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America Anti-Venom Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa Anti-Venom Sales Breakdown by Type (2018-2023)

 2 Global Anti-Venom Market Competition by Company
    2.1 Global Top Players by Anti-Venom Sales (2018-2023)
    2.2 Global Top Players by Anti-Venom Revenue (2018-2023)
    2.3 Global Top Players by Anti-Venom Price (2018-2023)
    2.4 Global Top Manufacturers Anti-Venom Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Anti-Venom Market Competitive Situation and Trends
        2.5.1 Anti-Venom Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Venom Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Venom as of 2022)
    2.7 Date of Key Manufacturers Enter into Anti-Venom Market
    2.8 Key Manufacturers Anti-Venom Product Offered
    2.9 Mergers & Acquisitions, Expansion

 3 Anti-Venom Status and Outlook by Region
    3.1 Global Anti-Venom Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global Anti-Venom Historic Market Size by Region
        3.2.1 Global Anti-Venom Sales in Volume by Region (2018-2023)
        3.2.2 Global Anti-Venom Sales in Value by Region (2018-2023)
        3.2.3 Global Anti-Venom Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global Anti-Venom Forecasted Market Size by Region
        3.3.1 Global Anti-Venom Sales in Volume by Region (2024-2029)
        3.3.2 Global Anti-Venom Sales in Value by Region (2024-2029)
        3.3.3 Global Anti-Venom Sales (Volume & Value), Price and Gross Margin (2024-2029)

 4 Global Anti-Venom by Application
    4.1 Anti-Venom Market Segment by Application
        4.1.1 Non-profit Institutions
        4.1.2 Hospitals and Clinic
    4.2 Global Anti-Venom Market Size by Application
        4.2.1 Global Anti-Venom Market Size Overview by Application (2018-2029)
        4.2.2 Global Anti-Venom Historic Market Size Review by Application (2018-2023)
        4.2.3 Global Anti-Venom Forecasted Market Size by Application (2024-2029)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America Anti-Venom Sales Breakdown by Application (2018-2023)
        4.3.2 Europe Anti-Venom Sales Breakdown by Application (2018-2023)
        4.3.3 Asia-Pacific Anti-Venom Sales Breakdown by Application (2018-2023)
        4.3.4 Latin America Anti-Venom Sales Breakdown by Application (2018-2023)
        4.3.5 Middle East and Africa Anti-Venom Sales Breakdown by Application (2018-2023)

 5 North America Anti-Venom by Country
    5.1 North America Anti-Venom Historic Market Size by Country
        5.1.1 North America Anti-Venom Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America Anti-Venom Sales in Volume by Country (2018-2023)
        5.1.3 North America Anti-Venom Sales in Value by Country (2018-2023)
    5.2 North America Anti-Venom Forecasted Market Size by Country
        5.2.1 North America Anti-Venom Sales in Volume by Country (2024-2029)
        5.2.2 North America Anti-Venom Sales in Value by Country (2024-2029)

 6 Europe Anti-Venom by Country
    6.1 Europe Anti-Venom Historic Market Size by Country
        6.1.1 Europe Anti-Venom Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe Anti-Venom Sales in Volume by Country (2018-2023)
        6.1.3 Europe Anti-Venom Sales in Value by Country (2018-2023)
    6.2 Europe Anti-Venom Forecasted Market Size by Country
        6.2.1 Europe Anti-Venom Sales in Volume by Country (2024-2029)
        6.2.2 Europe Anti-Venom Sales in Value by Country (2024-2029)

 7 Asia-Pacific Anti-Venom by Region
    7.1 Asia-Pacific Anti-Venom Historic Market Size by Region
        7.1.1 Asia-Pacific Anti-Venom Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific Anti-Venom Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific Anti-Venom Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific Anti-Venom Forecasted Market Size by Region
        7.2.1 Asia-Pacific Anti-Venom Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific Anti-Venom Sales in Value by Region (2024-2029)

 8 Latin America Anti-Venom by Country
    8.1 Latin America Anti-Venom Historic Market Size by Country
        8.1.1 Latin America Anti-Venom Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America Anti-Venom Sales in Volume by Country (2018-2023)
        8.1.3 Latin America Anti-Venom Sales in Value by Country (2018-2023)
    8.2 Latin America Anti-Venom Forecasted Market Size by Country
        8.2.1 Latin America Anti-Venom Sales in Volume by Country (2024-2029)
        8.2.2 Latin America Anti-Venom Sales in Value by Country (2024-2029)

 9 Middle East and Africa Anti-Venom by Country
    9.1 Middle East and Africa Anti-Venom Historic Market Size by Country
        9.1.1 Middle East and Africa Anti-Venom Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa Anti-Venom Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa Anti-Venom Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa Anti-Venom Forecasted Market Size by Country
        9.2.1 Middle East and Africa Anti-Venom Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa Anti-Venom Sales in Value by Country (2024-2029)

 10 Company Profiles
    10.1 CSL
        10.1.1 CSL Company Information
        10.1.2 CSL Introduction and Business Overview
        10.1.3 CSL Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 CSL Anti-Venom Products Offered
        10.1.5 CSL Recent Development
    10.2 Merck
        10.2.1 Merck Company Information
        10.2.2 Merck Introduction and Business Overview
        10.2.3 Merck Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 Merck Anti-Venom Products Offered
        10.2.5 Merck Recent Development
    10.3 BTG
        10.3.1 BTG Company Information
        10.3.2 BTG Introduction and Business Overview
        10.3.3 BTG Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 BTG Anti-Venom Products Offered
        10.3.5 BTG Recent Development
    10.4 Pfizer
        10.4.1 Pfizer Company Information
        10.4.2 Pfizer Introduction and Business Overview
        10.4.3 Pfizer Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
        10.4.4 Pfizer Anti-Venom Products Offered
        10.4.5 Pfizer Recent Development
    10.5 Haffkine Bio-Pharmaceutical
        10.5.1 Haffkine Bio-Pharmaceutical Company Information
        10.5.2 Haffkine Bio-Pharmaceutical Introduction and Business Overview
        10.5.3 Haffkine Bio-Pharmaceutical Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
        10.5.4 Haffkine Bio-Pharmaceutical Anti-Venom Products Offered
        10.5.5 Haffkine Bio-Pharmaceutical Recent Development
    10.6 Rare Disease Therapeutics
        10.6.1 Rare Disease Therapeutics Company Information
        10.6.2 Rare Disease Therapeutics Introduction and Business Overview
        10.6.3 Rare Disease Therapeutics Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
        10.6.4 Rare Disease Therapeutics Anti-Venom Products Offered
        10.6.5 Rare Disease Therapeutics Recent Development
    10.7 Flynn Pharma
        10.7.1 Flynn Pharma Company Information
        10.7.2 Flynn Pharma Introduction and Business Overview
        10.7.3 Flynn Pharma Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
        10.7.4 Flynn Pharma Anti-Venom Products Offered
        10.7.5 Flynn Pharma Recent Development
    10.8 Vins Bioproducts
        10.8.1 Vins Bioproducts Company Information
        10.8.2 Vins Bioproducts Introduction and Business Overview
        10.8.3 Vins Bioproducts Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
        10.8.4 Vins Bioproducts Anti-Venom Products Offered
        10.8.5 Vins Bioproducts Recent Development
    10.9 Bharat Serums and Vaccines
        10.9.1 Bharat Serums and Vaccines Company Information
        10.9.2 Bharat Serums and Vaccines Introduction and Business Overview
        10.9.3 Bharat Serums and Vaccines Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
        10.9.4 Bharat Serums and Vaccines Anti-Venom Products Offered
        10.9.5 Bharat Serums and Vaccines Recent Development
    10.10 Serum Biotech
        10.10.1 Serum Biotech Company Information
        10.10.2 Serum Biotech Introduction and Business Overview
        10.10.3 Serum Biotech Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
        10.10.4 Serum Biotech Anti-Venom Products Offered
        10.10.5 Serum Biotech Recent Development
    10.11 MicroPharm
        10.11.1 MicroPharm Company Information
        10.11.2 MicroPharm Introduction and Business Overview
        10.11.3 MicroPharm Anti-Venom Sales, Revenue and Gross Margin (2018-2023)
        10.11.4 MicroPharm Anti-Venom Products Offered
        10.11.5 MicroPharm Recent Development

 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 Anti-Venom Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Anti-Venom Industrial Chain Analysis
    11.4 Anti-Venom Market Dynamics
        11.4.1 Anti-Venom Industry Trends
        11.4.2 Anti-Venom Market Drivers
        11.4.3 Anti-Venom Market Challenges
        11.4.4 Anti-Venom Market Restraints

 12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 Anti-Venom Distributors
    12.3 Anti-Venom Downstream Customers

 13 Research Findings and Conclusion

 14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

List of Tables
    Table 1. Major Company of Polyvalent Anti-Venom
    Table 2. Major Company of Monovalent Anti-Venom
    Table 3. Global Anti-Venom Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 4. Global Anti-Venom Sales by Type (2018-2023) & (K Vials)
    Table 5. Global Anti-Venom Sales Market Share in Volume by Type (2018-2023)
    Table 6. Global Anti-Venom Sales by Type (2018-2023) & (US& Million)
    Table 7. Global Anti-Venom Market Share in Value by Type (2018-2023)
    Table 8. Global Anti-Venom Price by Type (2018-2023) & (USD/Vial)
    Table 9. Global Anti-Venom Sales by Type (2024-2029) & (K Vials)
    Table 10. Global Anti-Venom Sales Market Share in Volume by Type (2024-2029)
    Table 11. Global Anti-Venom Sales by Type (2024-2029) & (US$ Million)
    Table 12. Global Anti-Venom Sales Market Share in Value by Type (2024-2029)
    Table 13. Global Anti-Venom Price by Type (2024-2029) & (USD/Vial)
    Table 14. North America Anti-Venom Sales by Type (2018-2023) & (K Vials)
    Table 15. North America Anti-Venom Sales by Type (2018-2023) & (US$ Million)
    Table 16. Europe Anti-Venom Sales (K Vials) by Type (2018-2023)
    Table 17. Europe Anti-Venom Sales by Type (2018-2023) & (US$ Million)
    Table 18. Asia-Pacific Anti-Venom Sales (K Vials) by Type (2018-2023)
    Table 19. Asia-Pacific Anti-Venom Sales by Type (2018-2023) & (US$ Million)
    Table 20. Latin America Anti-Venom Sales (K Vials) by Type (2018-2023)
    Table 21. Latin America Anti-Venom Sales by Type (2018-2023) & (US$ Million)
    Table 22. Middle East and Africa Anti-Venom Sales (K Vials) by Type (2018-2023)
    Table 23. Middle East and Africa Anti-Venom Sales by Type (2018-2023) & (US$ Million)
    Table 24. Global Anti-Venom Sales by Company (2018-2023) & (K Vials)
    Table 25. Global Anti-Venom Sales Share by Company (2018-2023)
    Table 26. Global Anti-Venom Revenue by Company (2018-2023) & (US$ Million)
    Table 27. Global Anti-Venom Revenue Share by Company (2018-2023)
    Table 28. Global Market Anti-Venom Price by Company (2018-2023) & (USD/Vial)
    Table 29. Global Anti-Venom Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 30. Global Anti-Venom Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Venom as of 2022)
    Table 32. Date of Key Manufacturers Enter into Anti-Venom Market
    Table 33. Key Manufacturers Anti-Venom Product Type
    Table 34. Mergers & Acquisitions, Expansion Plans
    Table 35. Global Anti-Venom Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Global Anti-Venom Sales by Region (2018-2023) & (K Vials)
    Table 37. Global Anti-Venom Sales Market Share in Volume by Region (2018-2023)
    Table 38. Global Anti-Venom Sales by Region (2018-2023) & (US$ Million)
    Table 39. Global Anti-Venom Sales Market Share in Value by Region (2018-2023)
    Table 40. Global Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 41. Global Anti-Venom Sales by Region (2024-2029) & (K Vials)
    Table 42. Global Anti-Venom Sales Market Share in Volume by Region (2024-2029)
    Table 43. Global Anti-Venom Sales by Region (2024-2029) & (US$ Million)
    Table 44. Global Anti-Venom Sales Market Share in Value by Region (2024-2029)
    Table 45. Global Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2024-2029)
    Table 46. Global Anti-Venom Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 47. Global Anti-Venom Sales by Application (2018-2023) & (K Vials)
    Table 48. Global Anti-Venom Sales Market Share in Volume by Application (2018-2023)
    Table 49. Global Anti-Venom Sales by Application (2018-2023) & (US$ Million)
    Table 50. Global Anti-Venom Sales Market Share in Value by Application (2018-2023)
    Table 51. Global Anti-Venom Price by Application (2018-2023) & (USD/Vial)
    Table 52. Global Anti-Venom Sales by Application (2024-2029) & (K Vials)
    Table 53. Global Anti-Venom Sales Market Share in Volume by Application (2024-2029)
    Table 54. Global Anti-Venom Sales by Application (2024-2029) & (US$ Million)
    Table 55. Global Anti-Venom Sales Market Share in Value by Application (2024-2029)
    Table 56. Global Anti-Venom Price by Application (2024-2029) & (USD/Vial)
    Table 57. North America Anti-Venom Sales by Application (2018-2023) (K Vials) 
    Table 58. North America Anti-Venom Sales by Application (2018-2023) & (US$ Million)
    Table 59. Europe Anti-Venom Sales by Application (2018-2023) (K Vials) 
    Table 60. Europe Anti-Venom Sales by Application (2018-2023) & (US$ Million)
    Table 61. Asia-Pacific Anti-Venom Sales by Application (2018-2023) (K Vials) 
    Table 62. Asia-Pacific Anti-Venom Sales by Application (2018-2023) & (US$ Million)
    Table 63. Latin America Anti-Venom Sales by Application (2018-2023) (K Vials) 
    Table 64. Latin America Anti-Venom Sales by Application (2018-2023) & (US$ Million)
    Table 65. Middle East and Africa Anti-Venom Sales by Application (2018-2023) (K Vials) 
    Table 66. Middle East and Africa Anti-Venom Sales by Application (2018-2023) & (US$ Million)
    Table 67. North America Anti-Venom Sales by Country (2018-2023) & (K Vials)
    Table 68. North America Anti-Venom Sales Market Share in Volume by Country (2018-2023)
    Table 69. North America Anti-Venom Sales by Country (2018-2023) & (US$ Million)
    Table 70. North America Anti-Venom Sales Market Share in Value by Country (2018-2023)
    Table 71. North America Anti-Venom Sales by Country (2024-2029) & (K Vials)
    Table 72. North America Anti-Venom Sales Market Share in Volume by Country (2024-2029)
    Table 73. North America Anti-Venom Sales by Country (2024-2029) & (US$ Million)
    Table 74. North America Anti-Venom Sales Market Share in Value by Country (2024-2029)
    Table 75. Europe Anti-Venom Sales by Country (2018-2023) & (K Vials)
    Table 76. Europe Anti-Venom Sales Market Share in Volume by Country (2018-2023)
    Table 77. Europe Anti-Venom Sales by Country (2018-2023) & (US$ Million)
    Table 78. Europe Anti-Venom Sales Market Share in Value by Country (2018-2023)
    Table 79. Europe Anti-Venom Sales by Country (2024-2029) & (K Vials)
    Table 80. Europe Anti-Venom Sales Market Share in Volume by Country (2024-2029)
    Table 81. Europe Anti-Venom Sales by Country (2024-2029) & (US$ Million)
    Table 82. Europe Anti-Venom Sales Market Share in Value by Country (2024-2029)
    Table 83. Asia-Pacific Anti-Venom Sales by Region (2018-2023) & (K Vials)
    Table 84. Asia-Pacific Anti-Venom Sales Market Share in Volume by Region (2018-2023)
    Table 85. Asia-Pacific Anti-Venom Sales by Region (2018-2023) & (US$ Million)
    Table 86. Asia-Pacific Anti-Venom Sales Market Share in Value by Region (2018-2023)
    Table 87. Asia-Pacific Anti-Venom Sales by Region (2024-2029) & (K Vials)
    Table 88. Asia-Pacific Anti-Venom Sales Market Share in Volume by Region (2024-2029)
    Table 89. Asia-Pacific Anti-Venom Sales by Region (2024-2029) & (US$ Million)
    Table 90. Asia-Pacific Anti-Venom Sales Market Share in Value by Region (2024-2029)
    Table 91. Latin America Anti-Venom Sales by Country (2018-2023) & (K Vials)
    Table 92. Latin America Anti-Venom Sales Market Share in Volume by Country (2018-2023)
    Table 93. Latin America Anti-Venom Sales by Country (2018-2023) & (US$ Million)
    Table 94. Latin America Anti-Venom Sales Market Share in Value by Country (2018-2023)
    Table 95. Latin America Anti-Venom Sales by Country (2024-2029) & (K Vials)
    Table 96. Latin America Anti-Venom Sales Market Share in Volume by Country (2024-2029)
    Table 97. Latin America Anti-Venom Sales by Country (2024-2029) & (US$ Million)
    Table 98. Latin America Anti-Venom Sales Market Share in Value by Country (2024-2029)
    Table 99. Middle East and Africa Anti-Venom Sales by Country (2018-2023) & (K Vials)
    Table 100. Middle East and Africa Anti-Venom Sales Market Share in Volume by Country (2018-2023)
    Table 101. Middle East and Africa Anti-Venom Sales by Country (2018-2023) & (US$ Million)
    Table 102. Middle East and Africa Anti-Venom Sales Market Share in Value by Country (2018-2023)
    Table 103. Middle East and Africa Anti-Venom Sales by Country (2024-2029) & (K Vials)
    Table 104. Middle East and Africa Anti-Venom Sales Market Share in Volume by Country (2024-2029)
    Table 105. Middle East and Africa Anti-Venom Sales by Country (2024-2029) & (US$ Million)
    Table 106. Middle East and Africa Anti-Venom Sales Market Share in Value by Country (2024-2029)
    Table 107. CSL Company Information
    Table 108. CSL Introduction and Business Overview
    Table 109. CSL Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 110. CSL Anti-Venom Product
    Table 111. CSL Recent Development
    Table 112. Merck Company Information
    Table 113. Merck Introduction and Business Overview
    Table 114. Merck Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 115. Merck Anti-Venom Product
    Table 116. Merck Recent Development
    Table 117. BTG Company Information
    Table 118. BTG Introduction and Business Overview
    Table 119. BTG Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 120. BTG Anti-Venom Product
    Table 121. BTG Recent Development
    Table 122. Pfizer Company Information
    Table 123. Pfizer Introduction and Business Overview
    Table 124. Pfizer Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 125. Pfizer Anti-Venom Product
    Table 126. Pfizer Recent Development
    Table 127. Haffkine Bio-Pharmaceutical Company Information
    Table 128. Haffkine Bio-Pharmaceutical Introduction and Business Overview
    Table 129. Haffkine Bio-Pharmaceutical Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 130. Haffkine Bio-Pharmaceutical Anti-Venom Product
    Table 131. Haffkine Bio-Pharmaceutical Recent Development
    Table 132. Rare Disease Therapeutics Company Information
    Table 133. Rare Disease Therapeutics Introduction and Business Overview
    Table 134. Rare Disease Therapeutics Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 135. Rare Disease Therapeutics Anti-Venom Product
    Table 136. Rare Disease Therapeutics Recent Development
    Table 137. Flynn Pharma Company Information
    Table 138. Flynn Pharma Introduction and Business Overview
    Table 139. Flynn Pharma Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 140. Flynn Pharma Anti-Venom Product
    Table 141. Flynn Pharma Recent Development
    Table 142. Vins Bioproducts Company Information
    Table 143. Vins Bioproducts Introduction and Business Overview
    Table 144. Vins Bioproducts Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 145. Vins Bioproducts Anti-Venom Product
    Table 146. Vins Bioproducts Recent Development
    Table 147. Bharat Serums and Vaccines Company Information
    Table 148. Bharat Serums and Vaccines Introduction and Business Overview
    Table 149. Bharat Serums and Vaccines Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 150. Bharat Serums and Vaccines Anti-Venom Product
    Table 151. Bharat Serums and Vaccines Recent Development
    Table 152. Serum Biotech Company Information
    Table 153. Serum Biotech Introduction and Business Overview
    Table 154. Serum Biotech Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 155. Serum Biotech Anti-Venom Product
    Table 156. Serum Biotech Recent Development
    Table 157. MicroPharm Company Information
    Table 158. MicroPharm Introduction and Business Overview
    Table 159. MicroPharm Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2018-2023)
    Table 160. MicroPharm Anti-Venom Product
    Table 161. MicroPharm Recent Development
    Table 162. Key Raw Materials Lists
    Table 163. Raw Materials Key Suppliers Lists
    Table 164. Anti-Venom Market Trends
    Table 165. Anti-Venom Market Drivers
    Table 166. Anti-Venom Market Challenges
    Table 167. Anti-Venom Market Restraints
    Table 168. Anti-Venom Distributors List
    Table 169. Anti-Venom Downstream Customers
    Table 170. Research Programs/Design for This Report
    Table 171. Key Data Information from Secondary Sources
    Table 172. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Venom Product Picture
    Figure 2. Global Anti-Venom Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Anti-Venom Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Anti-Venom Sales Status and Outlook (2018-2029) & (K Vials)
    Figure 5. Product Picture of Polyvalent Anti-Venom
    Figure 6. Global Polyvalent Anti-Venom Sales YoY Growth (2018-2029) & (K Vials)
    Figure 7. Product Picture of Monovalent Anti-Venom
    Figure 8. Global Monovalent Anti-Venom Sales YoY Growth (2018-2029) & (K Vials)
    Figure 9. Global Anti-Venom Sales by Type (2018-2029) & (US$ Million)
    Figure 10. Global Anti-Venom Sales Market Share by Type in 2022 & 2029
    Figure 11. North America Anti-Venom Sales Market Share in Volume by Type in 2022
    Figure 12. North America Anti-Venom Sales Market Share in Value by Type in 2022
    Figure 13. Europe Anti-Venom Sales Market Share in Volume by Type in 2022
    Figure 14. Europe Anti-Venom Sales Market Share in Value by Type in 2022
    Figure 15. Asia-Pacific Anti-Venom Sales Market Share in Volume by Type in 2022
    Figure 16. Asia-Pacific Anti-Venom Sales Market Share in Value by Type in 2022
    Figure 17. Latin America Anti-Venom Sales Market Share in Volume by Type in 2022
    Figure 18. Latin America Anti-Venom Sales Market Share in Value by Type in 2022
    Figure 19. Middle East and Africa Anti-Venom Sales Market Share in Volume by Type in 2022
    Figure 20. Middle East and Africa Anti-Venom Sales Market Share in Value by Type in 2022
    Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Venom Sales in 2022
    Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Venom Revenue in 2022
    Figure 23. Anti-Venom Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 24. Product Picture of Non-profit Institutions
    Figure 25. Global Non-profit Institutions Sales YoY Growth (2018-2029) & (K Vials)
    Figure 26. Product Picture of Hospitals and Clinic
    Figure 27. Global Hospitals and Clinic Sales YoY Growth (2018-2029) & (K Vials)
    Figure 28. Global Anti-Venom Sales by Application (2018-2029) & (US$ Million)
    Figure 29. Global Anti-Venom Sales Market Share by Application in 2022 & 2029
    Figure 30. North America Anti-Venom Sales Market Share in Volume by Application in 2022
    Figure 31. North America Anti-Venom Sales Market Share in Value by Application in 2022
    Figure 32. Europe Anti-Venom Sales Market Share in Volume by Application in 2022
    Figure 33. Europe Anti-Venom Sales Market Share in Value by Application in 2022
    Figure 34. Asia-Pacific Anti-Venom Sales Market Share in Volume by Application in 2022
    Figure 35. Asia-Pacific Anti-Venom Sales Market Share in Value by Application in 2022
    Figure 36. Latin America Anti-Venom Sales Market Share in Volume by Application in 2022
    Figure 37. Latin America Anti-Venom Sales Market Share in Value by Application in 2022
    Figure 38. Middle East and Africa Anti-Venom Sales Market Share in Value by Application in 2022
    Figure 39. Key Raw Materials Price
    Figure 40. Anti-Venom Manufacturing Cost Structure
    Figure 41. Anti-Venom Industrial Chain Analysis
    Figure 42. Channels of Distribution
    Figure 43. Distributors Profiles
    Figure 44. Bottom-up and Top-down Approaches for This Report
    Figure 45. Data Triangulation
    Figure 46. Key Executives Interviewed

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings.

Anti-Venom report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-Venom market is projected to reach US$ 1283.7 million in 2029, increasing from US$ 959.2 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029. Demand from Non-profit Institutions and Hospitals and Clinic are the major drivers for the industry.

CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Anti-Venom market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
    CSL
    Merck
    BTG
    Pfizer
    Haffkine Bio-Pharmaceutical
    Rare Disease Therapeutics
    Flynn Pharma
    Vins Bioproducts
    Bharat Serums and Vaccines
    Serum Biotech
    MicroPharm

Segment by Type
    Polyvalent Anti-Venom
    Monovalent Anti-Venom

Segment by Application
    Non-profit Institutions
    Hospitals and Clinic

Segment by Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Anti-Venom market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anti-Venom, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anti-Venom industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Anti-Venom in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anti-Venom introduction, etc. Anti-Venom Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Anti-Venom market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.